MapLight Therapeutics is a biopharmaceutical company dedicated to improving the lives of patients with CNS disorders and we’re on a mission to develop more effective and innovative therapies for these patients. Using our proprietary optogenetics and 3D spatial transcriptomics platform, we are identifying a pipeline of targeted therapies for a spectrum of serious CNS disorders.